• THAT   AND
  • THAT   AND


Homo sapiens v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) (ERBB2), transcript variant 1, mRNA.


RefSeq Accession Definition Sequence Price Select
NM_004448 Homo sapiens v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) (ERBB2), transcript variant 1, mRNA. Full Lenth $1618.40
ORF Sequence $1318.80


RefSeq Version NM_004448.2, 54792095
Length 4624 bp
Structure linear
Update Date 01-MAY-2011
Organism Homo sapiens (human)
Definition Homo sapiens v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) (ERBB2), transcript variant 1, mRNA.
Product receptor tyrosine-protein kinase erbB-2 isoform a
Comment

Summary: This gene encodes a member of the epidermal growth factor (EGF) receptor family of receptor tyrosine kinases. This protein has no ligand binding domain of its own and therefore cannot bind growth factors. However, it does bind tightly to other ligand-bound EGF receptor family members to form a heterodimer, stabilizing ligand binding and enhancing kinase-mediated activation of downstream signalling pathways, such as those involving mitogen-activated protein kinase and phosphatidylinositol-3 kinase. Allelic variations at amino acid positions 654 and 655 of isoform a (positions 624 and 625 of isoform b) have been reported, with the most common allele, Ile654/Ile655, shown here. Amplification and/or overexpression of this gene has been reported in numerous cancers, including breast and ovarian tumors. Alternative splicing results in several additional transcript variants, some encoding different isoforms and others that have not been fully characterized. [provided by RefSeq].


Transcript Variant: This variant (1) represents the shorter transcript but encodes the longer isoform (a).

RefSeq NP_004439.2
CDS 239..4006
Exon (1)1..311
Exon (2)1..311
Exon (3)312..463
Exon (4)464..677
Exon (5)678..812
Exon (6)813..881
Exon (7)882..997
Exon (8)998..1139
Exon (9)1140..1259
Exon (10)1260..1386
Exon (11)1387..1460
Exon (12)1461..1551
Exon (13)1552..1751
Exon (14)1752..1884
Exon (15)1885..1975
Exon (16)1976..2136
Exon (17)2137..2184
Exon (18)2185..2323
Exon (19)2324..2446
Exon (20)2447..2545
Exon (21)2546..2731
Exon (22)2732..2887
Exon (23)2888..2963
Exon (24)2964..3110
Exon (25)3111..3208
Exon (26)3209..3397
Exon (27)3398..3650
Exon (28)3651..4624
Translation MELAALCRWGLLLALLPPGAASTQVCTGTDMKLRLPASPETHLDMLRHLYQGCQVVQGNL ELTYLPTNASLSFLQDIQEVQGYVLIAHNQVRQVPLQRLRIVRGTQLFEDNYALAVLDNG DPLNNTTPVTGASPGGLRELQLRSLTEILKGGVLIQRNPQLCYQDTILWKDIFHKNNQLA LTLIDTNRSRACHPCSPMCKGSRCWGESSEDCQSLTRTVCAGGCARCKGPLPTDCCHEQC AAGCTGPKHSDCLACLHFNHSGICELHCPALVTYNTDTFESMPNPEGRYTFGASCVTACP YNYLSTDVGSCTLVCPLHNQEVTAEDGTQRCEKCSKPCARVCYGLGMEHLREVRAVTSAN IQEFAGCKKIFGSLAFLPESFDGDPASNTAPLQPEQLQVFETLEEITGYLYISAWPDSLP DLSVFQNLQVIRGRILHNGAYSLTLQGLGISWLGLRSLRELGSGLALIHHNTHLCFVHTV PWDQLFRNPHQALLHTANRPEDECVGEGLACHQLCARGHCWGPGPTQCVNCSQFLRGQEC VEECRVLQGLPREYVNARHCLPCHPECQPQNGSVTCFGPEADQCVACAHYKDPPFCVARC PSGVKPDLSYMPIWKFPDEEGACQPCPINCTHSCVDLDDKGCPAEQRASPLTSIISAVVG ILLVVVLGVVFGILIKRRQQKIRKYTMRRLLQETELVEPLTPSGAMPNQAQMRILKETEL RKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSP YVSRLLGICLTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLEDVR LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRFT HQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYMIMVKCWM IDSECRPRFRELVSEFSRMARDPQRFVVIQNEDLGPASPLDSTFYRSLLEDDDMGDLVDA EEYLVPQQGFFCPDPAPGAGGMVHHRHRSSSTRSGGGDLTLGLEPSEEEAPRSPLAPSEG AGSDVFDGDLGMGAAKGLQSLPTHDPSPLQRYSEDPTVPLPSETDGYVAPLTCSPQPEYV NQPDVRPQPPSPREGPLPAARPAGATLERPKTLSPGKNGVVKDVFAFGGAVENPEYLTPQ GGAAPQPHPPPAFSPAFDNLYYWDQDPPERGAPPSTFKGTPTAENPEYLGLDVPV
Order your protein of interest with our Guaranteed or It's Free Service now! For details, please click here.
Position Chain Variation Link
337+a, gdbSNP:4252610
474+a, cdbSNP:61737968
619+c, gdbSNP:4252613
766+c, tdbSNP:56114611
828+c, tdbSNP:113619125
1388+, gdbSNP:67451917
1507+c, tdbSNP:35757908
1564+g, tdbSNP:4252632
1594+g, tdbSNP:4252633
1609+a, gdbSNP:2230698
1654+c, tdbSNP:61737967
1681+c, tdbSNP:55984118
1792+, gdbSNP:67116789
1804..1805+, tdbSNP:67881774
1807+a, gdbSNP:55928971
1924+a, gdbSNP:4252635
2011..2012+, gdbSNP:72478177
2045..2046+, gdbSNP:72125310
2167+c, tdbSNP:56110910
2198+a, gdbSNP:1801201
2201+a, g, tdbSNP:1136201
2244..2245+, gdbSNP:67526367
2346+g, tdbSNP:34602395
2501..2502+cc, ttdbSNP:121913469
2502+c, tdbSNP:121913470
2541+c, tdbSNP:56366519
2543+c, gdbSNP:121913468
2564+a, gdbSNP:28933369
2567+g, tdbSNP:121913471
2744+c, tdbSNP:104886008
2758+a, gdbSNP:104886011
2773+c, tdbSNP:137852788
2806+c, tdbSNP:104886009
2808+a, gdbSNP:28933370
2843+c, tdbSNP:104886010
2851..2852+, tdbSNP:66920285
2943+a, cdbSNP:114799025
2978+a, gdbSNP:28933368
3018+c, gdbSNP:2172826
3222+, gdbSNP:67430188
3308+c, tdbSNP:4252654
3316+c, tdbSNP:4252655
3322+, gdbSNP:67841145
3324+, gdbSNP:66515843
3384+a, gdbSNP:104886025
3551+a, gdbSNP:111611886
3679+c, tdbSNP:112561362
3746+c, gdbSNP:61552325
3746+, c, gdbSNP:1058808
3769+a, gdbSNP:4252656
3885+a, cdbSNP:55943169
3943+c, tdbSNP:4252657
3995+a, gdbSNP:36085723
4011+g, tdbSNP:2230700
4072+c, tdbSNP:4252658
4081+, adbSNP:4252659
4082+, adbSNP:80243420
4094..4095+, cdbSNP:66498387
4128..4129+, gdbSNP:36042695
4166..4167+, cdbSNP:35040721
4196+, tdbSNP:67751411
4377+, adbSNP:71753268
4419+c, gdbSNP:4252660
4597+c, tdbSNP:4252661
Gene SymbolERBB2
Gene SynonymCD340; HER-2; HER-2/neu; HER2; MLN 19; NEU; NGL; TKR1
Chromosome17
Locus Map17q21.1
All Transcripts NM_004448 , NM_001005862
Title Hunk is required for HER2/neu-induced mammary tumorigenesis .
Author Yeh,E.S., Yang,T.W., Jung,J.J., Gardner,H.P., Cardiff,R.D. and Chodosh,L.A.
Journal J. Clin. Invest. 121 (3), 866-879 (2011)
Title Expression and significance of HER family receptors in neuroblastic tumors .
Author Izycka-Swieszewska,E., Wozniak,A., Drozynska,E., Kot,J., Grajkowska,W., Klepacka,T., Perek,D., Koltan,S., Bien,E. and Limon,J.
Journal Clin. Exp. Metastasis 28 (3), 271-282 (2011)
Title Polymalic acid-based nanobiopolymer provides efficient systemic breast cancer treatment by inhibiting both HER2/neu receptor synthesis and activity .
Author Inoue,S., Ding,H., Portilla-Arias,J., Hu,J., Konda,B., Fujita,M., Espinoza,A., Suhane,S., Riley,M., Gates,M., Patil,R., Penichet,M.L., Ljubimov,A.V., Black,K.L., Holler,E. and Ljubimova,J.Y.
Journal Cancer Res. 71 (4), 1454-1464 (2011)
Title ADAM 10 is associated with gastric cancer progression and prognosis of patients .
Author Wang,Y.Y., Ye,Z.Y., Li,L., Zhao,Z.S., Shao,Q.S. and Tao,H.Q.
Journal J Surg Oncol 103 (2), 116-123 (2011)
Title [HER2 expression in gastric cancer in Peru] .
Author Beltran Garate,B. and Yabar Berrocal,A.
Journal Rev Gastroenterol Peru 30 (4), 324-327 (2010)
Title Expression and characterization of the p85 subunit of the phosphatidylinositol 3-kinase complex and a related p85 beta protein by using the baculovirus expression system .
Author Gout,I., Dhand,R., Panayotou,G., Fry,M.J., Hiles,I., Otsu,M. and Waterfield,M.D.
Journal Biochem. J. 288 (PT 2), 395-405 (1992)
Title Regulated coupling of the Neu receptor to phosphatidylinositol 3'-kinase and its release by oncogenic activation .
Author Peles,E., Lamprecht,R., Ben-Levy,R., Tzahar,E. and Yarden,Y.
Journal J. Biol. Chem. 267 (17), 12266-12274 (1992)
Title Elevated content of the tyrosine kinase substrate phospholipase C-gamma 1 in primary human breast carcinomas .
Author Arteaga,C.L., Johnson,M.D., Todderud,G., Coffey,R.J., Carpenter,G. and Page,D.L.
Journal Proc. Natl. Acad. Sci. U.S.A. 88 (23), 10435-10439 (1991)
Title G to A polymorphism at amino acid codon 655 of the human erbB-2/HER2 gene .
Author Papewalis,J., Nikitin,A.Yu. and Rajewsky,M.F.
Journal Nucleic Acids Res. 19 (19), 5452 (1991)
Title Oncogenic forms of the neu/HER2 tyrosine kinase are permanently coupled to phospholipase C gamma .
Author Peles,E., Levy,R.B., Or,E., Ullrich,A. and Yarden,Y.
Journal EMBO J. 10 (8), 2077-2086 (1991)

Our customer service representatives are available 24 hours a day, Monday through Friday; please contact us anytime for assistance.

Secured Online Quotation
Email: gene@genscript.com
Phone: 1-877-436-7274 (Toll-Free) 1-732-885-9188
Fax: 1-732-210-0262 1-732-885-5878